The purpose of this study is to evaluate the safety and efficacy of dutasteride in reducing drinking and heavy drinking in men and women with alcohol use disorder. The investigators hypothesize that dutasteride 1 mg per day will be well tolerated in this patient population and that, compared to placebo treatment, dutasteride will result in a greater reduction in drinks per week and in the frequency of heavy drinking days.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Heavy Drinking Days Per Week for Dutasteride vs. Placebo Groups
Timeframe: 12 weeks (from initiation to end of treatment phase 1)
Change in Drinks Per Week in Dutasteride vs. Placebo Groups
Timeframe: 12 weeks (from initiation to end of treatment phase 1)